Substandard drugs: a potential crisis for public health
dc.contributor.author | Johnston, A | en_US |
dc.contributor.author | Holt, DW | en_US |
dc.date.accessioned | 2016-06-01T15:16:01Z | |
dc.date.available | 2013-11-01 | en_US |
dc.date.issued | 2014-08 | en_US |
dc.date.submitted | 2016-05-31T14:57:00.434Z | |
dc.identifier.issn | 0306-5251 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12629 | |
dc.format.extent | 218 - 243 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | en_US |
dc.rights | CC-BY-NC-ND | |
dc.subject | drug quality | en_US |
dc.subject | falsification | en_US |
dc.subject | inspection | en_US |
dc.subject | regulation | en_US |
dc.subject | substandard | en_US |
dc.title | Substandard drugs: a potential crisis for public health | en_US |
dc.type | Article | |
dc.rights.holder | © 2013 The Authors. | |
dc.identifier.doi | 10.1111/bcp.12298 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340244800003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 78 | en_US |